Elderly also appear vulnerable to RSV virus, doctors advocate for vaccinations

Doctors emphasize the need for vaccinations against the RS virus for vulnerable elderly patients with chronic lung conditions, similar to infants. Despite the effectiveness of available vaccines, reimbursement for elderly patients remains uncertain in the Netherlands. Long-term hospitalizations due to the RS virus have been significant, with many elderly patients requiring emergency care during winter months. Other countries provide full or partial reimbursement for these vaccines, leading to reduced hospital admissions. The Dutch Health Institute plans to reassess the situation in 2027, considering new evidence on vaccine effectiveness for at-risk groups.